The forecasted sold production of opacifying preparations for X-ray examinations and diagnostic reagents in France shows a decreasing trend from 2024 to 2028. Starting at €744.25 million in 2024, the value steadily declines through the years, reaching €730.85 million in 2028. If we compare this forecast to the actual value from 2023, which stood at €747 million, there is a noticeable downward trajectory. The year-on-year variation reveals a consistent decrease—from 2024 to 2025, the decline is around 0.45%, and it continues similarly each following year. The compound annual growth rate (CAGR) over the five-year forecast period indicates a steady contraction of about 0.46% per annum.
Future trends to watch include potential market disruptions such as advancements in diagnostic technologies that might alter demand, healthcare policy changes, and shifts in global supply chains that could influence production costs and efficiency. Keeping an eye on regulatory adjustments and innovations in medical imaging will be crucial for anticipating further market developments.
